Apocrine Neoplasm clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for

  • Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

    Sorry, in progress, not accepting new patients

    This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the…

    Costa Mesa, California and other locations

Last updated: